Enzymes

DHFR (Dihydrofolate Reductase)

Enzyme reducing dihydrofolate to THF; target of methotrexate; essential for maintaining folate pool.

DHFR (Dihydrofolate Reductase) pathway diagram

Dihydrofolate Reductase (DHFR) catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF) using NADPH.

This reaction is essential because: 1) dietary folic acid must be reduced to THF to be active, and 2) when thymidylate synthase uses 5,10-methyleneTHF to make thymidine for DNA, DHF is produced and must be recycled back to THF.

DHFR is the target of methotrexate (used in cancer and autoimmune disease), trimethoprim (antibiotic), and pyrimethamine (antimalarial). These drugs cause folate depletion by blocking THF regeneration. Folic acid (synthetic) requires DHFR for activation, while 5-MTHF (methylfolate) bypasses DHFR and may be preferred when DHFR is limited or inhibited.

DHFR (Dihydrofolate Reductase) Discussion